Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S4W-14145 · Session 4

Further to the answer to question S4W-13200 by Michael Matheson on 5 March 2013, what restrictions relating to new medicines apply to ulipr…

Answered Asked by Helen Eadie Lab Lodged 4 Apr 2013

The question

To ask the Scottish Government, further to the answer to question S4W-13200 by Michael Matheson on 5 March 2013, what restrictions relating to new medicines apply to ulipristal acetate that are additional to the restriction removed on 9 November 2012 and under what conditions it can be made available without prescription.

The answer

Answered by Michael Matheson on 25 Apr 2013 · 21 days after it was lodged, on time

Ulipristal acetate is licensed as an emergency hormonal contraception. For this indication it is a prescription only medicine. The usual route for obtaining the medicine is via prescription from a qualified prescriber.
Exceptionally, it may be possible for ulipristal acetate to be obtained through a patient group direction (PGD) facility where such a direction has been put in place by a NHS board.
It is for NHS boards to determine when to establish a PGD and for what service. Scottish Government does not hold information on NHS board PGDs.

In the Official Report

No contribution in the Official Report cites S4W-14145 by reference.